Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

1.

Hypertension and Life-Threatening Bleeding in Children with Relapsed AML Treated with FLT3 Inhibitors.

Yılmaz Karapınar D, Karadaş N, Önder Siviş Z, Balkan C, Kavaklı K, Aydınok Y.

Turk J Haematol. 2015 Apr 27. doi: 10.4274/tjh.2014.0250. [Epub ahead of print]

PMID:
25912283
2.

Treatment of compensatory hyperhidrosis of the trunk with radiofrequency ablation.

Deniz S, Kavaklı K, Çaylak H, Purtuloğlu T, Sapmaz E, İnangil G, Atım A, Gürkök S, Kurt E.

Agri. 2015 Jan;27(1):42-6. doi: 10.5505/agri.2015.37167.

3.

Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.

Sahbudak Bal Z, Yilmaz Karapinar D, Karadas N, Sen S, Onder Sivis Z, Akinci AB, Balkan C, Kavakli K, Vardar F, Aydinok Y.

Mycoses. 2015 Apr;58(4):225-32. doi: 10.1111/myc.12303. Epub 2015 Feb 27.

PMID:
25728069
4.

Parathyroid adenoma upstaging the lung cancer.

Okuyucu K, Kavakli K, Ozaydın S, Karahatay S, Karatas O, Doğan D.

Ann Nucl Med. 2015 May;29(4):371-4. doi: 10.1007/s12149-015-0946-x. Epub 2015 Jan 25.

PMID:
25618011
5.

Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II).

Kavakli K, Yang R, Rusen L, Beckmann H, Tseneklidou-Stoeter D, Maas Enriquez M.

J Thromb Haemost. 2015 Mar;13(3):360-9.

PMID:
25546368
6.

Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia.

Duyu M, Durmaz B, Gunduz C, Vergin C, Yilmaz Karapinar D, Aksoylar S, Kavakli K, Cetingul N, Irken G, Yaman Y, Ozkinay F, Cogulu O.

Biomed Res Int. 2014;2014:967585. doi: 10.1155/2014/967585. Epub 2014 May 14.

7.

Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa.

Lentz SR, Ehrenforth S, Karim FA, Matsushita T, Weldingh KN, Windyga J, Mahlangu JN; adept™2 investigators.

J Thromb Haemost. 2014 Aug;12(8):1244-53. doi: 10.1111/jth.12634. Epub 2014 Jul 16.

8.

Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study.

Lalezari S, Coppola A, Lin J, Enriquez MM, Tseneklidou-Stoeter D, Powell J, Ingerslev J; LIPLONG Investigators.

Haemophilia. 2014 May;20(3):354-61.

PMID:
24847524
9.

A Polymorphism in the IL-5 Gene is Associated with Inhibitor Development in Severe Hemophilia A Patients.

Fidancı ID, Zülfikar B, Kavaklı K, Ar MC, Kılınç Y, Başlar Z, Cağlayan SH.

Turk J Haematol. 2014 Mar;31(1):17-24. doi: 10.4274/Tjh.2012.0197. Epub 2014 Mar 5.

10.

Inhibitors to factor VII in congenital factor VII deficiency.

Batorova A, Mariani G, Kavakli K, de Saez AR, Caliskan U, Karimi M, Pinotti M, Napolitano M, Dolce A, Sørensen B, Ingerslev J; STER Study Group.

Haemophilia. 2014 Mar;20(2):e188-91. doi: 10.1111/hae.12376. No abstract available.

PMID:
24533960
11.

The Prevalence of von Willebrand Disease and Significance of in Vitro Bleeding Time (PFA-100) in von Willebrand Disease Screening in the İzmir Region.

Sap F, Kavaklı T, Kavaklı K, Dizdarer C.

Turk J Haematol. 2013 Mar;30(1):40-7. doi: 10.4274/tjh.2011.0020. Epub 2013 Mar 5.

12.

Reconstruction with a patient-specific titanium implant after a wide anterior chest wall resection.

Turna A, Kavakli K, Sapmaz E, Arslan H, Caylak H, Gokce HS, Demirkaya A.

Interact Cardiovasc Thorac Surg. 2014 Feb;18(2):234-6. doi: 10.1093/icvts/ivt408. Epub 2013 Nov 13.

13.

Partial anomalous pulmonary venous return to azygos vein with absent segmental bronchus.

Kavakli K, Gaudet M, Balderson SS, Wahidi M, D'Amico TA.

Ann Thorac Surg. 2013 Oct;96(4):1486. doi: 10.1016/j.athoracsur.2013.03.041. No abstract available.

PMID:
24088473
14.

Leukapheresis in childhood acute leukemias: single-center experience.

Yilmaz D, Karapinar B, Karadaş N, Duyu M, Yazici P, Ay Y, Balkan C, Aydinok Y, Kavakli K.

Pediatr Hematol Oncol. 2014 May;31(4):318-26. doi: 10.3109/08880018.2013.818747. Epub 2013 Aug 29.

PMID:
23988130
15.

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.

Gringeri A, Leissinger C, Cortesi PA, Jo H, Fusco F, Riva S, Antmen B, Berntorp E, Biasoli C, Carpenter S, Kavakli K, Morfini M, Négrier C, Rocino A, Schramm W, Windyga J, Zülfikar B, Mantovani LG.

Haemophilia. 2013 Sep;19(5):736-43. doi: 10.1111/hae.12178. Epub 2013 Jun 4.

PMID:
23731246
16.

Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.

Karapinar DY, Karadaş N, Ay Y, Akin M, Balkan C, Aydinok Y, Kavakli K.

Pediatr Hematol Oncol. 2014 Feb;31(1):20-8. doi: 10.3109/08880018.2013.792894. Epub 2013 Apr 30.

PMID:
23627541
17.

Real-world outcomes with recombinant factor VIIa treatment of acute bleeds in haemophilia patients with inhibitors: results from the international ONE registry.

Chambost H, Santagostino E, Laffan M, Kavakli K; ONE Registry Steering Committee on behalf of the investigators.

Haemophilia. 2013 Jul;19(4):571-7. doi: 10.1111/hae.12140. Epub 2013 Apr 5.

PMID:
23557542
18.

Effect of radiofrequency ablation and comparison with surgical sympathectomy in palmar hyperhidrosis.

Purtuloglu T, Atim A, Deniz S, Kavakli K, Sapmaz E, Gurkok S, Kurt E, Turan A.

Eur J Cardiothorac Surg. 2013 Jun;43(6):e151-4. doi: 10.1093/ejcts/ezt024. Epub 2013 Feb 21.

PMID:
23428574
19.

Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A.

Tiede A, Brand B, Fischer R, Kavakli K, Lentz SR, Matsushita T, Rea C, Knobe K, Viuff D.

J Thromb Haemost. 2013 Apr;11(4):670-8. doi: 10.1111/jth.12161.

PMID:
23398640
20.

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Astermark J, Donfield SM, Gomperts ED, Schwarz J, Menius ED, Pavlova A, Oldenburg J, Kessing B, DiMichele DM, Shapiro AD, Winkler CA, Berntorp E; Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Blood. 2013 Feb 21;121(8):1446-54. doi: 10.1182/blood-2012-06-434803. Epub 2012 Dec 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk